624 results on '"Lançon, Christophe"'
Search Results
2. Development of the PREMIUM computerized adaptive testing for measuring the access and care coordination for patients with severe mental illness
3. Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study
4. Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia
5. Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)
6. Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort
7. Psychometric properties of the BIRT Motivation Questionnaire (BMQ), a self-measure of avolition in individuals with schizophrenia
8. Validation and refinement of the clinical staging model in a French cohort of outpatient with schizophrenia (FACE-SZ)
9. Perceived Changes in Sexual Interest and Distress About Discrepant Sexual Interest During the First Phase of COVID-19 Pandemic: A Multi-Country Assessment in Cohabiting Partnered Individuals
10. Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study
11. Childhood Trauma increases suicidal behaviour in a treatment-resistant depression population: a FACE-DR report
12. Sexual dysfunctions in schizophrenia: Beyond antipsychotics. A systematic review
13. Recurrent major depressive disorder's impact on end-of-life care of cancer: A nationwide study
14. Outcome prediction with a social cognitive battery: a multicenter longitudinal study
15. End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database
16. Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset
17. Prévalence de la dépression majeure en France en population générale et en populations spécifiques de 2000 à 2018 : une revue systématique de la littérature
18. Modernizing quality of life assessment: development of a multidimensional computerized adaptive questionnaire for patients with schizophrenia
19. Dépression dans les schizophrénies : d’une évidence à l’obscurité, réflexions pour son diagnostic et sa prise en charge
20. Predictive value of dorso-lateral prefrontal connectivity for rTMS response in treatment-resistant depression: A brain perfusion SPECT study
21. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort
22. Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report.
23. The cognitive, affective motivational and clinical longitudinal determinants of apathy in schizophrenia
24. Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder
25. Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report
26. Functional brain substrate of quality of life in patients with schizophrenia: A brain SPECT multidimensional analysis
27. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia
28. Dépression résistante : les stratégies de potentialisation
29. Dépression résistante : les autres stratégies thérapeutiques
30. Dépression résistante : les stratégies de changement et d’association de médicaments antidépresseurs
31. Quelle définition pour la dépression résistante ?
32. Psychiatric advance directives for people living with schizophrenia, bipolar I disorders, or schizoaffective disorders: Study protocol for a randomized controlled trial – DAiP study
33. Perceptual abnormalities related to sensory gating deficit are core symptoms in adults with ADHD
34. Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review
35. Association of metabolic syndrome with sensory gating deficits in patients with chronic schizophrenia
36. Comorbidités psychiatriques et qualité de vie chez les sujets adultes à haut potentiel intellectuel : relations avec l’estime de soi
37. L’inaccessible presque touché. Connaissance minimale en psychologie de la santé à l’usage de l’étudiant en médecine
38. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia
39. Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression
40. Perceptually or conceptually driven recognition: On the specificities of the memory deficit in schizophrenia
41. Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study
42. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set
43. How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?
44. Validation of the French sensory gating inventory: A confirmatory factor analysis
45. Predictive Factors of Response to Mindfulness-Based Cognitive Therapy (Mbct) for Patients with Depressive Symptoms: The Machine Learning’s Point of View
46. Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: A structural equation modeling approach
47. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
48. La kétamine dans le traitement du trouble dépressif aigu sévère
49. Auteurs
50. La disponibilité à la réhabilitation psychosociale : une étape importante pour amorcer des changements
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.